Case 01: Esophageal Cancer
“Combined immunotherapy for cancer” was performed as treatment for residual metastasis from advanced esophageal cancer refractory to standard therapies, by combining the cancer vaccine therapy (one course) and a drug to inhibit immunosuppression.
Prolonged inhibition of tumor growth
4 weeks after treatment initiation
7 weeks after treatment initiation
The tumor marker turned to decrease